Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-035024
Filing Date
2022-11-03
Accepted
2022-11-03 20:46:12
Documents
2
Period of Report
2022-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1537
2 EX-24 DOCUMENT attachment1.htm EX-24 3859
  Complete submission text file 0000899243-22-035024.txt   6937
Mailing Address 5980 HORTON STREET SUITE 600 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 600 EMERYVILLE CA 94608 510-250-7800
OmniAb, Inc. (Issuer) CIK: 0001846253 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O LIGAND PHARMACEUTICALS INC 3911 SORRENTO VALLEY BOULEVARD, STE 100 SAN DIEGO CA 92121
Business Address
Cochran Jennifer R. (Reporting) CIK: 0001872349 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40720 | Film No.: 221359891